A Brave New Mind - Psychedelic Medicine in Aotearoa
Dr Will Evans and Susi Maclean
13 episodes
7 months ago
We wrap up season 1 back where we started, with Dr BJ Miller, one of the world's leading voices in palliative care. The connection between psychedelics and his field is a strong one, with a lot of the current research focused on easing suffering at the end of life. Amongst other things, BJ and Will talk about how they think about their own deaths, their visions for the future of their profession, the need for more humanity in medicine and where spirituality fits, and BJ's new online palliativ...
All content for A Brave New Mind - Psychedelic Medicine in Aotearoa is the property of Dr Will Evans and Susi Maclean and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We wrap up season 1 back where we started, with Dr BJ Miller, one of the world's leading voices in palliative care. The connection between psychedelics and his field is a strong one, with a lot of the current research focused on easing suffering at the end of life. Amongst other things, BJ and Will talk about how they think about their own deaths, their visions for the future of their profession, the need for more humanity in medicine and where spirituality fits, and BJ's new online palliativ...
We wrap up season 1 back where we started, with Dr BJ Miller, one of the world's leading voices in palliative care. The connection between psychedelics and his field is a strong one, with a lot of the current research focused on easing suffering at the end of life. Amongst other things, BJ and Will talk about how they think about their own deaths, their visions for the future of their profession, the need for more humanity in medicine and where spirituality fits, and BJ's new online palliativ...
While we count down to the end of the year and the end of Season One, we thought it was timely to take stock of the emerging field of psychedelic medicine in New Zealand. In this episode, Will covers off the country's first psychedelic medicine conference, the momentum that's building in the research community, what's happening with the only psychedelic that's legal here for therapy - ketamine - and what lies ahead. Be sure to tune in next week as we wrap up the season the way we starte...
Psychologist Dr Rosalind Watts is best known for her work at Imperial College London where she has done pioneering work in using psilocybin for depression. More recently, she became Clinical Director at Synthesis Retreats, an organisation that offers medically supervised psychedelic retreats in Amsterdam. Having had experience working with psychedelics in both research and commercial settings, Ros brings a unique perspective to the conversation. Amongst other things In thi...
Dr Marg Ross is a senior psychologist working in Palliative Care at St Vincent’s Hospital, Melbourne, and the clinical lead in Australia’s first ever psychedelic medicine trial, which is looking at psilocybin and psychotherapy for end of life depression and anxiety. Marg had watched what was going on in the Northern Hemisphere with interest and waited for somebody to get a study off the ground in Australia before deciding nothing was going to happen in a hurry - so she’d better do it he...
Dr Steven Mandel and his son, Sam, run Ketamine Clinics of Los Angeles - one of the first infusion clinics in the United States. At KCLA they do ketamine infusions all day, every day, and they have developed their own regimen of personalised dosing that takes patients to optimal 'altitude' to change their minds, as well as their brains. The Mandels are firm believers in the value of stand alone ketamine infusions, even without psychotherapy, and say they've seen near-miraculous and la...
Professor David Nutt is the Chair of Neuropsychopharmacology at Imperial College London and a world-leading psychedelic researcher. He's a strong advocate for a rational, evidence based approach to psychedelics, and continues to, in his own words, 'call out the lies' about them, wherever he can. David is currently Chair of DrugScience and President of the European Brain Council, has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs ad...
Saj Razvi has been involved in psychedelic therapy from almost every angle - as a researcher in the MAPS MDMA trials, as a psychotherapist, and now as a trainer of others looking to incorporate psychedelics into their practice. Saj believes that psychedelics don't necessarily fit with traditional therapy, and so has created a modality designed specifically for work with them. He's a passionate advocate for these medicines, but also knows from first hand experience that things can go horrib...
Dr Geoff Noller is a medical anthropologist specialising in psychotropic drug research, with an emphasis on drug use as a cultural practice. We talked with Geoff about his work looking at kiwi attitudes to cannabis use, the nature of consciousness and reality, fears and prejudices around mind altering states and substances, and his experiences as principal investigator on an ibogaine study for opioid dependence. Our interview took place on the morning of the cannabis referendum decision – and...
Rick Doblin decided he wanted to be a psychedelic therapist when he was in his late teens, and has since dedicated his life to building the foundations needed to enable him - and others - to do the work legally, safely and effectively. He founded the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986, a research and advocacy organisation that has spent decades researching the use of psychedelics and cannabis as medicines. MAPS is now closer than anyone has ever ...
Psychedelic medicines have a long and chequered history - not the least because of wariness from the medical mainstream. That perception is changing fast, though, with a growing number of respected international researchers and clinicians pointing to the evidence of their potential to provide safer, faster and more effective treatments for mental illness and existential distress. There's a cultural shift going on, too, with support coming from unexpected quarters, including that of well-known...
Our chat with Dr Suresh Muthukumaraswamy took us down the kind of rabbit-hole that's becoming all too familiar as we continue our exploration of psychedelics as medicine. Despite - or because of - all the twists and turns it was an invigorating and thought provoking conversation, even if we did just scratch the surface of some of the perplexities and complexities of working with these medicines. Suresh is a neuroscientist and associate professor in the School of Pharmacy at the Univers...
A special bonus episode this week - with only a matter of days until the polls close, we thought we'd better get this one out pronto. West Auckland GP, Dr Graham Gulbransen, is a pioneer in the emerging field of medicinal cannabis. We had a great chat with him about the referendum, the reluctance of GPs to prescribe cannabis-based products and how the future could look if it's a 'yes' next Saturday. For the ethnobotanically curious, there's a mention of Will's brand new mineral water pr...
Dr BJ Miller is best known for his Ted Talk, What Really Matters At The End Of Life https://tinyurl.com/y3tn7wfr. BJ is not a psychedelic medicine practitioner, but has a lot to say about altered states and their role in palliative care, end of life choices, and what's going on in California as more psychedelics are decriminalised for medicinal and recreational use. We talk with BJ about these things and more, including how he came to terms with the accident that cost him his legs and...
A Brave New Mind - Psychedelic Medicine in Aotearoa
We wrap up season 1 back where we started, with Dr BJ Miller, one of the world's leading voices in palliative care. The connection between psychedelics and his field is a strong one, with a lot of the current research focused on easing suffering at the end of life. Amongst other things, BJ and Will talk about how they think about their own deaths, their visions for the future of their profession, the need for more humanity in medicine and where spirituality fits, and BJ's new online palliativ...
